Flamingo Pharma (uk) Ltd

Flamingo Pharma Uk Ltd from Harrow UK is a large, active company founded ten years ago, in 2014. It employs nine people and holds £13,639,810 in assets, operating from a real address. The company is managed by three directors and owned by Thacker Ashwin. It’s a regular importer of pharmaceutical products, with recent activity recorded in January 2025.

The company’s website reveals it's a wholly-owned subsidiary of Flamingo Pharmaceuticals Ltd, committed to providing affordable medicines. Backed by manufacturing capabilities in India, Flamingo Pharma UK Ltd. is engaged in acquiring, developing, and marketing generic medicines in the UK and Europe. It designs its product portfolio to accommodate key therapeutic areas, with fast-moving generic products currently available for the UK market. The company aims to grow its UK and European operations, welcoming contacts from interested clients, ensuring cost-effective quality products with reliable supply.

The website details a wide range of products, including Allopurinol, Amitriptyline, Flucloxacillin, and various formulations of Metformin, all available with specific license types and pack details. It even offers patient safety information, encouraging reporting of side effects via the Yellow Card Scheme.

Financially, Flamingo Pharma Uk Ltd shows some concerning trends. Administrative expenses have increased significantly, jumping 160% to £3.4 million. Staff costs have also risen substantially, increasing by 55% to £1.3 million. Bank borrowings have decreased dramatically, falling 100% to zero. However, cash reserves have increased by 45% to £140,000. Creditors have decreased by 34%, suggesting improved debt management. The company’s size (meeting two of three criteria for a large company) helps it maintain a competitive edge, but the increased expenses warrant attention. The company’s financial statements were audited by John Cumming Ross Limited.

Overall, Flamingo Pharma Uk Ltd appears to be a sizable importer navigating a challenging financial landscape. While it maintains a broad product range and a commitment to quality, the increased expenses and reliance on bank borrowings suggest a need for careful financial management.

Registered in England/Wales under the registration number 09006526, with a registered address at HA1 2AX, United Kingdom, Harrow, Middlesex, First Floor Kirkland House, 11-15 Peterborough Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.